any willing provider

(redirected from Any Willing Provider Law)
Also found in: Financial.

any willing provider

A proposed model for providing healthcare in the UK in which patients would be able to select their care providers (here, providers refer to hospital trusts and independent hospitals, not individual practitioners as the word provider is usually defined in the US) from a list of those willing to offer it and which meet certain standards.
Mentioned in ?
References in periodicals archive ?
Arkansas' 1995 any willing provider law was blocked because both the U.S.
"Judge Lifts Ban on Any Willing Provider Law: Ruling Cites Supreme Court in Opening up State's Insurers." Arkansas Democrat-Gazette, February 14, p.
Several studies of any willing provider laws have shown that they increase the cost of care (Hellinger 1995; Jensen and Morrisey 1999; Rogal and Stenger 2001), and there have been a number of studies of the impact of specific patient protection laws (Hellinger 1996).
"If these fears are accurate, and we believe they are, then it is reasonable to expect health care costs to increase if the any willing provider law is adopted."
Mansfield said enforcement of the any willing provider law should increase St.
Any willing provider laws enable a hospital or physician to join these plans if they are willing to accept the terms and reimbursement rates already in place.
The 2006 edition adds sections on "any willing provider laws" and mandated coverage for cancer clinical trials.
Several states have enacted so-called any willing provider laws banning closed or preferred networks and enabling any pharmacy to participate in the network if it accepts required conditions and the stated reimbursement fees.
MCCLEAN, Va.--Members of the American Managed Care Pharmacy Association (AMCPA) have vowed to continue to oppose unitary pricing proposals as well as so-called any willing provider laws. The group held its fourth annual conference here recently and heard one speaker predict that the health care system of the future will feature the direct distribution of pharmaceutical products from manufacturers to the people who use them.